| NCT01980589 | phase1 | completed | 2013-08-01 | 2016-03-01 | Amgen | A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects |
| NCT03859427 | phase3 | completed | 2019-05-08 | 2023-03-31 | Amgen | A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma |
| NCT03512353 | phase2 | terminated | 2018-07-05 | 2020-01-16 | Amgen | A Study of Carfilzomib Plus Dexamethasone in Adults With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers |
| NCT01302392 | phase3 | completed | 2010-09-01 | 2014-07-01 | Amgen | A Study of Carfilzomib vs Best Supportive Care in Subjects With Relapsed and Refractory Multiple Myeloma |
| NCT00884312 | phase2 | completed | 2009-04-09 | 2017-05-17 | Amgen | A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols |